Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MPHOSPH9 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | TDRKH | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | ADAL | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | PSKH2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | ATP5L | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | KRBA1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | ARHGEF12 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | UBE2Q2L | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | RMI2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | HHLA3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |